1.
Clin Infect Dis
; 69(10): 1809-1811, 2019 10 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30901021
RESUMO
Bedaquiline was recommended by the World Health Organization as the preferred option in treatment of multidrug-resistant tuberculosis (MDR-TB) with long regimens. However, no recommendation was given for the short MDR-TB regimen. Data from our small cohort of patients who switched from injectable drug to bedaquiline suggest that a bedaquiline-based short regimen is effective and safe.